MANKIND.NS Stock — Price, Charts & Analysis

Mankind Pharma Limited (MANKIND.NS) has a trailing P/E of 48.34x and a forward P/E of 33.81x. This places MANKIND.NS in a premium earnings multiple territory based on the valuation data currently available on Worldtickers.

MANKIND.NS trades with 48.34x earnings on Worldtickers. Use valuation together with growth, balance sheet strength, and risk before deciding whether MANKIND.NS looks overvalued or undervalued.

MANKIND.NS's P/E of 48.34x should be judged against Healthcare peers, growth rate, margins, and balance sheet quality. A lower P/E may indicate value, while a higher P/E often means investors expect stronger future growth.

MANKIND.NS's trailing EPS is ₹49.32 and forward EPS is ₹70.51. Reported earnings growth is 29.60%, which helps show current profit momentum.

EPS, or earnings per share, shows how much profit Mankind Pharma Limited generated for each share. MANKIND.NS's trailing EPS is ₹49.32, and investors usually prefer EPS that is positive and growing over time.

Mankind Pharma Limited has a market cap of ₹984.58B, making MANKIND.NS a large-cap stock based on the current market value shown on Worldtickers.

MANKIND.NS's latest stock price on Worldtickers is ₹2,384.00. The latest move is -₹1.00 or -0.04%. Use the live quote, chart, volume, and 52-week range to judge the current trading context.

MANKIND.NS's quote includes a latest price of ₹2,384.00. The market open is ₹2,385.00. Previous close is ₹2,385.00. The intraday range is ₹2,365.60 to ₹2,407.20.

MANKIND.NS is down in the latest quote, with a move of -₹1.00 or -0.04%. To understand the reason, compare this move with news, earnings updates, analyst changes, sector performance, and market-wide direction.

MANKIND.NS generated ₹147.38B in trailing revenue. Revenue growth is 12.90%, which helps show whether demand is expanding or slowing.

MANKIND.NS's revenue growth is 12.90%, which is a strong demand signal in the latest available data. Investors usually compare revenue growth with margin trends and valuation to judge whether growth is profitable.

Yes, MANKIND.NS shows positive profitability metrics in the latest data available on Worldtickers. Net income to common shareholders is ₹20.43B.

Gross margin is 70.76%. Margins show how efficiently Mankind Pharma Limited turns revenue into profit.

Mankind Pharma Limited carries ₹63.12B and holds ₹22.08B in cash.

MANKIND.NS holds ₹22.08B on its balance sheet.

MANKIND.NS's book value per share is ₹394.85.

Yes, Mankind Pharma Limited pays a dividend of ₹2.00 per share annually. The dividend yield is 8.00%. The payout ratio is 2.02%.

MANKIND.NS's dividend yield is 8.00%. Its payout ratio is 2.02%, which helps judge dividend sustainability. Dividend investors usually prefer a reasonable yield, consistent cash flow, and a payout ratio that leaves room for reinvestment.

Worldtickers does not currently show a confirmed next ex-dividend date for MANKIND.NS. The page does show dividend rate and yield when available, and investors should confirm record and payment dates through Mankind Pharma Limited's investor relations materials.

Institutions hold 19.51% of MANKIND.NS shares. Insiders hold 75.40% of shares. Ownership mix helps investors understand how much of Mankind Pharma Limited is held by professional investors and company insiders.

MANKIND.NS has 413M shares outstanding. Float shares are 112.95M. Share count affects market cap, EPS, ownership percentages, and the impact of buybacks or dilution.

Insider activity can be useful context for MANKIND.NS, especially when multiple executives buy shares with their own money. Insider selling is harder to interpret because executives may sell for taxes, diversification, or planned compensation reasons.

Forward EPS for MANKIND.NS is ₹70.51. Earnings growth is 29.60%. Revenue growth is 12.90%. For earnings, investors usually watch EPS, revenue, margins, guidance, and management commentary.

MANKIND.NS's trailing EPS is ₹49.32. Forward EPS is ₹70.51. Use the earnings section on the page to compare reported results, estimates, and trend changes when those datasets are available.

MANKIND.NS is in the Healthcare sector. Its earnings multiple is 48.34x. Its latest displayed growth metric is 12.90%. Compare these figures with sector peers before deciding whether Mankind Pharma Limited is stronger or weaker than average.

MANKIND.NS trades at ₹2,384.00. The stock trades at 48.34x earnings. Whether to invest depends on your risk tolerance, time horizon, diversification, and view of Mankind Pharma Limited's fundamentals.

MANKIND.NS risks include company execution, valuation, competition in Healthcare, interest rates, and broad market volatility. Beta is 0.46, which helps estimate market sensitivity. No single stock should be evaluated without portfolio context.

MANKIND.NS should be compared with companies in Drug Manufacturers - Specialty & Generic. Its earnings multiple is 48.34x. Useful comparison points include revenue growth, margins, debt, cash flow, valuation, analyst targets, and price momentum.

Mankind Pharma Limited (MANKIND.NS) operates in Healthcare, specifically Drug Manufacturers - Specialty & Generic. Mankind Pharma Limited develops, manufactures, and markets pharmaceutical formulations and consumer healthcare products in India and internationally. The company develops pharmaceuticals for acute and chronic therapeutics in the areas of anti-infective, cardiovascular, gastrointestinal, gynaecology, urology, anti-diabetic, dermatology, pain/analgesics, neuro/CNS, vitamins/minerals/nutrients, respiratory, and other diseases. It also provides consumer healthcare products, such as condoms, pregnancy detection, emergen

MANKIND.NS trades on NSE. Exchange context matters because trading hours, liquidity, currency, and settlement rules can differ across markets.

MANKIND.NS stock is priced in INR on Worldtickers. Currency matters for international investors because exchange-rate moves can affect local-currency returns.

Mankind Pharma Limited's official website listed on Worldtickers is www.mankindpharma.com. Investor relations pages are useful for earnings releases, annual reports, filings, and shareholder presentations.

Mankind Pharma Limited employs about 20.45K people based on the latest company profile data available on Worldtickers. Workforce size helps investors understand company scale and operating complexity.

Mankind Pharma Limited is headquartered in New Delhi, India. Headquarters location can matter for currency, regulation, tax, labor market, and regional economic exposure.

MANKIND.NS is in the Healthcare sector and the Drug Manufacturers - Specialty & Generic industry. Sector context helps investors compare valuation, growth, margins, and risk against similar companies.

MANKIND.NS has traded between ₹1,909.70 and ₹2,674.00 over the past 52 weeks. At ₹2,384.00, it is 10.85% below the high and 24.84% above the low. The 52-week range helps gauge long-term price momentum.

MANKIND.NS is between its 50-day and 200-day moving averages, which suggests a mixed trend setup. Its 50-day moving average is ₹2,480.13 and its 200-day moving average is ₹2,276.39.

MANKIND.NS's RSI is 39.66. Readings below 30 are commonly viewed as oversold, above 70 as overbought, and the current reading suggests a neutral momentum setup.

MANKIND.NS's latest RSI reading is 39.66, which points to neutral momentum today. Traders usually confirm RSI with volume, trend, and nearby support or resistance.

Key support for MANKIND.NS is near ₹2,363.30. Key resistance is near ₹2,642.00. Breaks above resistance or below support can change the short-term technical setup.

MANKIND.NS's nearest reported support level is ₹2,363.30. A clean break below support can weaken the short-term setup, while repeated bounces can show demand.

MANKIND.NS's nearest reported resistance level is ₹2,642.00. A breakout above resistance can improve momentum, especially when volume confirms the move.

MANKIND.NS trades about 479.96K shares daily on average. The latest displayed volume is 343.26K shares. Volume helps show liquidity and whether trading interest is unusually high or low.

MANKIND.NS's MACD is -7.90, which is a negative momentum reading. MACD should be reviewed with price trend, moving averages, RSI, volume, and support or resistance levels.

MANKIND.NS is between its 50-day and 200-day moving averages, which suggests a mixed trend setup. RSI is 39.66 (neutral). MACD is bearish. Nearest support is around ₹2,363.30. Resistance is around ₹2,642.00. A buy decision should also consider valuation, earnings quality, risk tolerance, and position sizing.

MA20 is ₹2,454.51 (-2.87% from price). MA50 is ₹2,480.13 (-3.88% from price). MA200 is ₹2,276.39 (4.73% from price). The moving-average stack helps separate short-term momentum from long-term trend risk.

The server report currently confirms daily moving-average levels rather than a separate EMA-only value. MANKIND.NS's MA20 is ₹2,454.51. MA50 is ₹2,480.13. For EMA-specific overlays, use the live chart indicators and compare EMA direction with RSI, MACD, volume, support, and resistance.

MANKIND.NS's pivot is near ₹2,390.47. Support is near ₹2,363.30. Resistance is near ₹2,642.00. Price holding above pivot can support a constructive setup, while rejection near resistance can cap momentum.

The next lower support zone for MANKIND.NS is near ₹2,351.65. The next upper resistance zone is near ₹2,470.81. These levels help define risk and possible follow-through zones after a breakout or breakdown.

MANKIND.NS's Bollinger range is roughly ₹2,311.54 to ₹2,597.48. Band width is near 11.65%. Price near the upper band can show stretched upside momentum, while price near the lower band can show downside pressure or a possible mean-reversion zone.

MANKIND.NS's ATR-based typical daily range is about 2.24%. ATR helps size risk because wider ranges usually require wider stops or smaller position sizes.

Latest volume is 343.26K shares. Average volume is about 479.96K shares. Breakouts with rising relative volume are usually more reliable than moves on light participation.

MANKIND.NS's all-time high shown on Worldtickers is ₹3,054.80. Its all-time low is ₹1,242.00. All-time levels provide long-range context, but recent fundamentals and market conditions matter more for current decisions.

MANKIND.NS has a beta of 0.46, meaning it has historically been less volatile than the broad market. Beta is useful for judging how much a stock may move during broad market swings.